Immunohistochemistry indicated higher levels of NLRP3 in post-mortem tissues from COVID-19 patients compared to controls, and there were correlations with Casp1p20 and IL-18 and disease severity [63•]. This evidence concerns the gene NLRP3 and COVID-19.